Cargando…

Upregulation of Serum lncRNA DLEU1 Predicts Progression of Premalignant Endometrial Lesion and Unfavorable Clinical Outcome of Endometrial Cancer

OBJECTIVE: Long non-coding RNAs (lncRNAs) play a critical role in tumorigenesis. Upregulation of lncRNA deleted in lymphocytic leukemia 1 (DLEU1) has been reported in endometrial cancer (EC) tissues. This prospective study aimed to determine the potential clinical significance of serum lncRNA DLEU1...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shan, Lixia, Zhao, Tao, Wang, Yu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2020
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7750898/ https://www.ncbi.nlm.nih.gov/pubmed/33327893 http://dx.doi.org/10.1177/1533033820965589

Ejemplares similares

Exosomal-lncRNA DLEU1 Accelerates the Proliferation, Migration, and Invasion of Endometrial Carcinoma Cells by Regulating microRNA-E2F3
por: Jia, Jianjun, et al.
Publicado: (2020)

LncRNA DLEU1 contributes to colorectal cancer progression via activation of KPNA3
por: Liu, Tianyou, et al.
Publicado: (2018)

Knockdown lncRNA DLEU1 Inhibits Gliomas Progression and Promotes Temozolomide Chemosensitivity by Regulating Autophagy
por: Lv, Qiao-Li, et al.
Publicado: (2020)

Premalignant and malignant lesions in endometrial polyps in patients undergoing hysteroscopic polypectomy
por: Lenci, Marco Antonio, et al.
Publicado: (2014)

Noninvasive Predictor for Premalignant and Cancerous Lesions in Endometrial Polyps Diagnosed by Ultrasound
por: Xu, Jianying, et al.
Publicado: (2022)

ALDH1 expression predicts progression of premalignant lesions to cancer in Type I endometrial carcinomas
por: Mah, Vei, et al.
Publicado: (2021)

Rate of premalignant and malignant endometrial lesion in “low-risk” premenopausal women with abnormal uterine bleeding undergoing endometrial biopsy
por: Jha, Sangam, et al.
Publicado: (2021)

Knockdown of LncRNA DLEU2 Inhibits Cervical Cancer Progression via Targeting miR-128-3p
por: Wang, Bofei, et al.
Publicado: (2020)

UPF1 Participates in the Progression of Endometrial Cancer by Inhibiting the Expression of lncRNA PVT1
por: Xing, Tian-rong, et al.
Publicado: (2020)

Accuracy of cytological examination of Tao brush endometrial sampling in diagnosing endometrial premalignancy and malignancy
por: Raffone, Antonio, et al.
Publicado: (2022)

Identification of the 11-lncRNA signatures associated with the prognosis of endometrial carcinoma
por: Wan, Jing, et al.
Publicado: (2021)

Construction of implantation failure related lncRNA-mRNA network and identification of lncRNA biomarkers for predicting endometrial receptivity
por: Feng, Chun, et al.
Publicado: (2018)

Identification of lncRNA DLEU2 as a potential diagnostic biomarker and anti-inflammatory target for ulcerative colitis
por: Lin, Qiuling, et al.
Publicado: (2022)

Upregulated ENC1 predicts unfavorable prognosis and correlates with immune infiltration in endometrial cancer
por: He, Lingling, et al.
Publicado: (2022)

Reduced expression of lncRNA DLEU7-AS1 is a novel favorable prognostic factor in acute myeloid leukemia
por: Wang, Cui-zhu, et al.
Publicado: (2022)

LncRNA DCST1-AS1 Was Upregulated in Endometrial Carcinoma and May Sponge miR-92a-3p to Upregulate Notch1
por: Ke, Jieqi, et al.
Publicado: (2020)

Upregulated expression of LncRNA nicotinamide nucleotide transhydrogenase antisense RNA 1 is correlated with unfavorable clinical outcomes in cancers
por: Zhang, Chenghao, et al.
Publicado: (2020)

lncRNA DSCAM-AS1 facilitates the progression of endometrial cancer via miR-136-5p
por: Li, Luhong, et al.
Publicado: (2021)

lncRNA DLEU2 promotes gastric cancer progression through ETS2 via targeting miR-30a-5p
por: Han, Shuyi, et al.
Publicado: (2021)

lncRNA SNHG5 Modulates Endometrial Cancer Progression via the miR-25-3p/BTG2 Axis
por: Li, Shi, et al.
Publicado: (2019)

A novel lncRNA-focus expression signature for survival prediction in endometrial carcinoma
por: Zhou, Meng, et al.
Publicado: (2018)

Prediction of Clinical Outcome in Endometrial Carcinoma Based on a 3-lncRNA Signature
por: Ding, Hongmei, et al.
Publicado: (2022)

Necroptosis-Related LncRNA Signatures for Prognostic Prediction in Uterine Corpora Endometrial Cancer
por: Lin, Zhiheng, et al.
Publicado: (2022)

Comprehensive bioinformatic analyses of lncRNA-mediated ceRNA network for uterine corpus endometrial carcinoma
por: Cai, Yiran, et al.
Publicado: (2022)

Hepatitis B protein HBx binds the DLEU2 lncRNA to sustain cccDNA and host cancer-related gene transcription
por: Salerno, Debora, et al.
Publicado: (2020)

LncRNA DLEU1 Contributes to the Growth and Invasion of Colorectal Cancer via Targeting miR-320b/PRPS1
por: Xu, Dong, et al.
Publicado: (2021)

LncRNA CTBP1-AS2 sponges miR-216a to upregulate PTEN and suppress endometrial cancer cell invasion and migration
por: Wang, Qing-an-zi, et al.
Publicado: (2020)

ZIC2 upregulates lncRNA SNHG12 expression to promote endometrial cancer cell proliferation and migration by activating the Notch signaling pathway
por: Cai, Pengyu, et al.
Publicado: (2021)

Downregulation Of LncRNA PMS2L2 In Endometrial Adenocarcinoma Upon Carboplatin Treatment
por: Zhang, Dan, et al.
Publicado: (2019)

lncRNA DLEU2 acts as a miR-181a sponge to regulate SEPP1 and inhibit skeletal muscle differentiation and regeneration
por: Wang, Yao, et al.
Publicado: (2020)

Cancer-Related Triplets of mRNA-lncRNA-miRNA Revealed by Integrative Network in Uterine Corpus Endometrial Carcinoma
por: Liu, Chenglin, et al.
Publicado: (2017)

lncRNA-ZFAS1 promotes the progression of endometrial carcinoma by targeting miR-34b to regulate VEGFA expression
por: Zhu, Hongli, et al.
Publicado: (2021)

LncRNA MONC suppresses the malignant phenotype of Endometrial Cancer Stem Cells and Endometrial Carcinoma Cells by regulating the MiR-636/GLCE axis
por: Li, Yibing, et al.
Publicado: (2021)

TWIST1 expression and clinical significance in type I endometrial cancer and premalignant lesions: A retrospective clinical study
por: Shen, Junhua, et al.
Publicado: (2020)

lncRNA DLEU1 Modulates Proliferation, Inflammation, and Extracellular Matrix Degradation of Chondrocytes through Regulating miR-671-5p
por: Wu, Xiangkun, et al.
Publicado: (2022)

A novel necroptosis-related lncRNA signature for predicting prognosis and anti-cancer treatment response in endometrial cancer
por: He, Wei-Peng, et al.
Publicado: (2022)

LncRNA ABHD11‐AS1 promotes the development of endometrial carcinoma by targeting cyclin D1
por: Liu, Yao, et al.
Publicado: (2018)

Exploring lncRNA-Mediated Regulatory Networks in Endometrial Cancer Cells and the Tumor Microenvironment: Advances and Challenges
por: Dong, Peixin, et al.
Publicado: (2019)

Development of a novel immune-related lncRNA signature as a prognostic classifier for endometrial carcinoma
por: Liu, Jinhui, et al.
Publicado: (2021)

Ferroptosis-Related lncRNA for the Establishment of Novel Prognostic Signature and Therapeutic Response Prediction to Endometrial Carcinoma
por: Zhou, Xin-Ying, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_bj3q7i1g7cgkgfe6i1lknkqg4n